Clinical Use of Vibrational Coherence Tomography and Optical Coherence Tomography to Noninvasively Classify Skin Cancers: A New Telemedicine Technique
Main Article Content
Abstract
Background: Vibrational optical coherence tomography (VOCT) is a new digital technique that identifies cancerous cells, small friable blood vessels, and fibrotic tissues that are the hallmarks of epithelial cell derived skin cancers. This technique uses infrared light and acoustic sound to characterize the components of skin and skin lesions and the differences that occur during cancer. Initial studies focused on understanding the physiological changes that occur that are the basis for noninvasive classification of skin cancers.
Objective: To collect additional clinical optical coherence tomography (OCT) images of cancerous lesions to develop convolutional neural network models of basal cell carcinomas (BCCs), squamous cell carcinomas (SCCs), and melanomas with high sensitivities and specificities. The goal of this research is to produce digital images and AI models that can be used with telemedicine for remote classification of skin cancers.
Methods: OCT images of cancerous lesions were collected using the OptoScope and compared to images of normal skin using a convolutional neural network. The models are developed by comparing the intensity distribution and location of pixels contained in the OCT images.
Results: Gray scale and color-coded OCT images of normal skin, BCCs, SCCs and melanomas were evaluated using convolutional neural network models. The models predicted the type of lesions with sensitivity and specificity greater than 90%. These models were able to predict the correct clasifications of BCC, SCC, and melanomas consistent with the diagnoses based on lesion histopathology conducted by board certified dermatopathologists.
Conclusions: Results of OCT studies indicate that CNN models can classify different skin cancers in several minutes based on OCT images of BCC, SCC, and melanomas. Noninvasive use of the OptoScope provides digital information about skin cancers that can be used to classify skin cancers as part of an evaluation of patient lesions via telemedicine. This is particularly useful in areas where Dermatologists are in short supply and patient waiting times are prolonged. Evaluation using new digital techniques and the availability of approved topical treatments for these cancers will provide an effective manner to treat patients in rural areas where Dermatology visits are not readily available.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. https://gco.iarc.fr/today/en/fact-sheets-cancers, International Agency For Research on Cancer, accessed 8/22/2025.
3. www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/about/key-statistics.html accessed March 6, 2025.
4. Negrutiu, M.; Danescu, S.; Popa, T.; Focsan, M.; Vesa, S .C.; Baican, A. Advancements in Basal Cell Carcinoma Diagnosis: Non-Invasive Imaging and Multimodal Approach. J. Clin. Med. 2024, 13, 39. doi.org/ 10.3390/jcm13010039
5. Iannazzone SS, Ingordo V. Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel. Dermatol Pract Concept. 2018 Apr 30;8(2):129-131. doi: 10.5826/d pc.0802a12.
6. Tan IJ, Pathak GN, Silver FH. Topical Treatments for Basal Cell Carcinoma and Actinic Keratosis in the United States. Cancers (Basel). 2023 Aug 2;15 (15):3927. doi: 10.3390/cancers15153927.
7. Fan Q, Cohen S, John B, Riker AI. Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods. Ochsner J. 2015 Winter;15 (4):443-7.
8. Ahmady S, Nelemans PJ, Kelleners-Smeets NWJ, Arits AHMM, de Rooij MJM, Kessels JPHM, Essers BAB, Mosterd K. Surgical excision versus topical 5% 5-fluorouracil and photodynamic therapy in treatment of Bowen's disease: A multicenter randomized controlled trial. J Am Acad Dermatol. 2024 Jan;90(1):58-65. doi: 10.1016/j.jaad.2023.
9. Ferrante di Ruffano, L.; Dinnes, J.; Deeks, J.J.; Chuchu, N.; Bayliss, S.E.; Davenport, C.; Takwoingi, Y.; Godfrey, K.; O’Sullivan, C.; Matin, R.N.; et al. Optical coherence tomography for diagnosing skin cancer in adults. Cochrane Database Syst. Rev. 2018,12, CD013189.
10. Silver, F.H.; Deshmukh, T.; Patel, A.; Dhillon, J.; Bobra, A.; Nadiminti, H. Rapid Noninvasive Skin Screening for Basal Cell Carcinomas using Vibrational Optical Coherence Tomography. Br. J. Cancer Res. 2025, 8, 747–755.
11. Suneja T, Smith ED, Chen GJ, Zipperstein KJ, Fleischer AB Jr, Feldman SR. Waiting times to see a dermatologist are perceived as too long by dermatologists: implications for the dermatology workforce. Arch Dermatol. 2001 Oct;137(10):1303-7. doi: 10.1001/archderm.137.10.1303.
12. Weinstein DA, Konda S, Coldiron BM. Use of Skin Biopsies Among Dermatologists. Dermatol Surg. 2017 Nov;43(11):1348-1357. doi: 10.1097/DSS.000 0000000001188.
13. Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. doi: 10.1016/j.sintl.2021.100117. Epub 2021 Jul 24. PMID: 34806053; PMCID: PMC8590973.
14. Reed M, Huang J, Somers M, Hsueh L, Graetz I, Millman A, Muelly E, Gopalan A. Telemedicine Versus In-Person Primary Care: Treatment and Follow-up Visits. Ann Intern Med. 2023 Oct;176(10):1349-1357. doi: 10.7326/M23-1335. PMID: 37844311; PMCID: PMC11382601.
15. Zhiyue Su, Chengquan Li, Haitian Fu, Liyang Wang, Meilong Wu, Xiaobin Feng, Development and prospect of telemedicine,Intelligent Medicine, Volume 4, Issue 1,2024, Pages 1-9. doi.org/10.101 6/j.imed.2022.10.004.
16. Sud E, Anjankar A. Applications of Telemedicine in Dermatology. Cureus. 2022 Aug 7;14(8):e27740. doi: 10.7759/cureus.27740. PMID: 36106261; PMCID: PMC9445412.
17. Wolner ZJ, Yélamos O, Liopyris K, Rogers T, Marchetti MA, Marghoob AA. Enhancing Skin Cancer Diagnosis with Dermoscopy. Dermatol Clin. 2017 Oct;35(4):417-437. doi: 10.1016/j.det.2017.0 6.003. Epub 2017 Aug 7. PMID: 28886798; PMCID: PMC5659633.
18. Jung JM, Cho JY, Lee WJ, Chang SE, Lee MW, Won CH. Emerging Minimally Invasive Technologies for the Detection of Skin Cancer. J Pers Med. 2021 Sep 24;11(10):951. doi: 10.3390/jpm11100951.
19. Duniphin DD. Limited Access to Dermatology Specialty Care: Barriers and Teledermatology. Dermatol Pract Concept. 2023 Jan 1;13(1):e2023 031. doi: 10.5826/dpc.1301a31.
20. Silver, F.H.; Deshmukh, T.; Ryan, N.; Romm, A.; Nadiminti, H. “Fingerprinting” Benign and Cancerous Skin Lesions Using Vibrational Optical Coherence Tomography: Differentiation among Cancerous Lesion Types Based on the Presence of New Cells, Blood Vessels, and Fibrosis. Biomolecules 2022, 12,1332. https://doi.org/10.3390/biom12101332
21. Silver FH, Kelkar N, Deshmukh T, Horvath I, Shah RG. Mechano-Vibrational Spectroscopy of Tissues and Materials Using Vibrational Optical Coherence Tomography: A New Non-Invasive and Non-Destructive Technique. Recent Progress in Materials 2020; 2(2): 010; doi:10.21926/rpm.2002010.
22. Silver, F.H.; Deshmukh, T.; Patel, A.; Nadaminti, H. Use of Optical Coherence Tomography Images to Differentiate Between Normal Skin, Skin Lesions, and Melanoma: A Pilot Study. J. Cancer Sci. Therapy 2024, 4, 1751.
23. Silver FH, Deshmukh T, Ryan N, Room A, Nadiminti, H. Non-invasive characterization of different types of basal cell carcinomas (BCCs) using vibrational optical coherence to¬mography (VOCT): Can early lesions as small as 0.05 mm be identified by VOCT? Medical Research Archives 10(2).
24. Silver FH, Deshmukh T, Nadiminti H, Wassef
C, Pappert A, et al. Use of Optical Coherence Tomography images to Differentiate Between Normal Skin, Skin Lesions, and Melanoma: A Pilot Study. J Clin Med Img. 2024; V8(6): 1-11